Oncolytic vaccinia virus immunotherapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 16, 2024
Completion: Dec 31, 2027
Loading map...